Skip to content

NMIN

PEOPLE

NMIN leverages the research and entrepreneurial excellence of a pan-Canadian, multidisciplinary team.

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals. The BoD receives input from two Advisory Committees: the Executive & Nominating Committee, and the Finance & Audit Committee.

NMIN’s Management Team consists of the Scientific Director & CEO, the Associate Scientific Director, and the Executive Director.

NMIN’s Research program receives oversight and strategic direction from the Research Management Committee (RMC). Each of the program’s three Themes and two Core Facilities are further overseen by two Co-leaders.

The RMC receives input from three committees: the KTEE Advisory Committee, the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

The Administrative Centre Team provides support to the Research and the HQP programs, and implements the network’s administration, operations, IP, and communications cores on a day-to-day basis.

NMIN

PEOPLE

NMIN leverages the research and entrepreneurial excellence of a pan-Canadian, multidisciplinary team.

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals. The BoD receives input from two Advisory Committees: the Executive & Nominating Committee, and the Finance & Audit Committee.

NMIN’s Management Team consists of the Scientific Director & CEO, the Associate Scientific Director, and the Executive Director.

NMIN’s Research program receives oversight and strategic direction from the Research Management Committee (RMC). Each of the program’s three Themes and two Core Facilities are further overseen by two Co-leaders.

The RMC receives input from three bodies: the Commercialization Advisory Board (CAB), the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

The Administrative Centre Team provides support to the Research and the HQP programs, and implements the network’s administration, operations, IP, and communications cores on a day-to-day basis.

NMIN

GOVERNANCE

Board of Directors

NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals.

The BoD includes 10 individuals with leadership experience in areas ranging from law to corporate management. Committees of the Board include the Board Executive, Board Nomination, Audit and Finance, Conflict of Interest, and Ethics Advisory committees. Members of the BoD also form adhoc committees or special task forces as needed.

CHAIR: Inès Holzbaur

Co-Founder & Managing Partner, AmorChem

Michael Coughtrie

Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis

Professor, Department of Biochemistry and Molecular Biology, UBC

VICE-CHAIR: Lesley Esford

Board Director, Innovate BC; Chair, NMIN Finance & Audit Committee

CHAIR: Inès Holzbaur

Co-Founder & Managing Partner, AmorChem

Rachel Fernandez

Associate Vice-President, Research & Innovation, University of British Columbia

Vanessa Grant

Partner, Norton Rose Fulbright Canada LLP

David Martin

Managing Director & Head of Equity Research, Bloom Burton & Co

Parimal Nathwani

President and CEO
TIAP

Gilbert Walker

Scientific Director & CEO
University of Toronto

Jennyfer Zapata-Farfan

Observer: President & Chair, NHN Executive Committee

Christine Allen

Associate Vice-President & Vice-Provost, Strategic Initiatives, University of Toronto; Scientific Director & CEO, NMIN

Michael Coughtrie

Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis

Professor, Department of Biochemistry & Molecular Biology

VICE-CHAIR: Lesley Esford

Board Director, Innovate BC; Chair, NMIN Finance & Audit Committee

Rachel Fernandez

Associate Vice-President, Research & Innovation, University of British Columbia

Vanessa Grant

Partner, Norton Rose Fulbright Canada LLP

David Martin

Managing Director & Head of Equity Research, Bloom Burton & Co

Parimal Nathwani

President and CEO, TIAP
MaRS Innovation

Gilbert Walker

Scientific Director & CEO

Norma Sebestyen

Advisor, Health Innovation, Strategy and Commercialization

Rebecca Yu

Vice President, Market Access and External Affairs, Takeda Canada

NMIN

NETWORK MANAGEMENT

Management Team

NMIN’s Scientific Leadership Team is comprised of the Scientific Director, the Associate Scientific Director, and the Executive Director, who provide strategic leadership and overall management.

Pieter Cullis

Scientific Director & CEO

Gilbert Walker

Scientific Director & CEO

Afsaneh Lavasanifar

Associate Scientific Director

Diana Royce

Executive Director

Pieter Cullis

Scientific Director & CEO

Gilbert Walker

Scientific Director & CEO

Afsaneh Lavasanifar

Associate Scientific Director

Diana Royce

Executive Director

NMIN

research MANAGEMENT

Research Management Committee

With representatives from academic and industry partners, the Research Management Committee (RMC) is responsible for ongoing assessment of all projects and provides recommendations to the BoD regarding research priorities and budget allocations.

The RMC receives input from three committees: the Commercialization Advisory Board (CAB), the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

CHAIR: Terry M Allen

Professor Emerita, Pharmacology & Oncology, University of Alberta and Visiting Professor, Biochemistry & Molecular Medicine, University of British Columbia

Marcel Bally

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Nicolas Bertrand

Associate Professor
Université Laval

Anna Blakney

Grand Challenges Thrust 2 Co-leader
University of British Columbia

CHAIR: Terry M Allen

Professor Emerita, Pharmacology & Oncology, University of Alberta and Visiting Professor, Biochemistry & Molecular Medicine, University of British Columbia

Christine Allen

Scientific Director & CEO, NMIN
University of Toronto

Marcel Bally

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Nicolas Bertrand

Associate Professor
Université Laval

Anna Blakney

Grand Challenges Thrust 2 Co-leader
University of British Columbia

Warren Chan

Theme 3 Co-leader
University of Toronto

Connie Chen

Senior Director, Strategy & Corporate Development
FACIT

Pieter Cullis

Theme 2 & NanoCore Co-Leader
University of British Columbia

Emmanuel Ho

Associate Professor
University of Waterloo

Christian Kastrup

Theme 2 & NanoCore Co-Leader
University of British Columbia

Warren Chan

Theme 3 Co-leader
University of Toronto

Connie Chen

Senior Director, Strategy & Corporate Development
FACIT

Pieter Cullis

Theme 2 & NanoCore Co-Leader
University of British Columbia

Emmanuel Ho

Associate Professor
University of Waterloo

Shana Kelley

Theme 3 Leader
University of Toronto

Shyh-Dar (Star) Li

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Afsaneh Lavasanifar

Associate Scientific Director
University of Alberta

Larry Lynd

EHTA Platform Leader
University of British Columbia

David Martin

Board Representative
NMIN Board Member

Michel Meunier

Theme 3 Co-leader
École Polytechnique de Montréal

Norbert Maurer

External
Evonik Transferra

Christian Kastrup

Theme 2 & NanoCore Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Theme 1 & PharmaCore Co-Leader
University of British Columbia

Afsaneh Lavasanifar

Associate Scientific Director
University of Alberta

Larry Lynd

eHTA Platform Leader
University of British Columbia

David O’Neill

External
FACIT

Gilbert Walker

Scientific Director & CEO
University of Toronto

Kaley Wilson

Director, Business Development
Quark Venture

Karen Chan

Observer
NanoCore Operational Lead

Miffy Cheng

Observer
Theme 2 Research & KTEE Accelerator

David Martin

Board Representative
NMIN Board Member

Michel Meunier

Theme 3 Co-leader
École Polytechnique de Montréal

Gilbert Walker

Scientific Director & CEO
University of Toronto

Kaley Wilson

Director, Business Development
Quark Venture

Karen Chan

Observer
NanoCore Operational Lead

Miffy Cheng

Observer
Theme 2 Research & KTEE Accelerator

Nick Dragojlovic

Observer
eHTA Technical Lead

Nancy Dos Santos

Observer
PharmaCore Operational Lead

Sara Esam

Observer
NCE Secretariat

Ramya Kannan

Observer
Theme 1 Research & KTEE Accelerator

Michael Valic

Observer
NHN Vice-President

Nashmia Zia

Observer
Theme 3 Research & KTEE Accelerator

Nancy Dos Santos

Observer
PharmaCore Operational Lead

Sara Esam

Observer
NCE Secretariat

Ramya Kannan

Observer
Theme 1 Research & KTEE Accelerator

Nashmia Zia

Observer
Theme 3 Research & KTEE Accelerator

Michael Valic

Observer
NHN Vice-President

Research Theme & Core Facilities Leaders

NMIN research is organized into three themes, led by Theme Leaders: Targeted Drug Delivery, Gene Therapy, and Diagnostics, each consisting of up to 10 projects. The research themes are supported by two core facilities led by Core Leaders: NanoCore and PharmaCore

Theme 1: Targeted Drug Delivery

Marcel Bally

Theme Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Theme Co-Leader
University of British Columbia

Ramya Kannan

Theme 1 Research & KTEE Accelerator

Theme 2: Gene Therapy

Pieter Cullis

Theme Co-Leader
University of British Columbia

Christian Kastrup

Theme Co-Leader
University of British Columbia

Miffy Cheng

Theme 2 Research & KTEE Accelerator

Theme 1: Targeted Drug Delivery

Marcel Bally

Theme Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Theme Co-Leader
University of British Columbia

Theme 2: Gene Therapy

Pieter Cullis

Theme Co-Leader
University of British Columbia

Christian Kastrup

Theme Co-Leader
University of British Columbia

Theme 3: Diagnostics

Warren Chan

Theme Co-Leader
University of Toronto

Michel Meunier

Theme 3 Co-Leader
École Polytechnique de Montréal

Nashmia Zia

Theme 3 Research & KTEE Accelerator

Theme 3: Diagnostics

HQP Program

Warren Chan

Theme Co-Leader
University of Toronto

Michel Meunier

Theme Co-Leader

Mark Pereira

Theme Accelerator
University of Toronto

NanoCore

PharmaCore

Pieter Cullis

Core Co-Leader
University of British Columbia

Christian Kastrup

Core Co-Leader
University of British Columbia

Karen Chan

Core Operational Lead
University of British Columbia

Marcel Bally

Core Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Core Co-Leader
University of British Columbia

Nancy Dos Santos

Core Operational Lead
BC Cancer Agency

ieHTA

PharmaCore

Larry Lynd

Leader
University of British Columbia

Nick Dragojlovic

Technical Lead
University of British Columbia

Karen Chan

Core Operational Lead
University of British Columbia

Marcel Bally

Core Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Core Co-Leader
University of British Columbia

Nancy Dos Santos

Core Operational Lead
BC Cancer Agency

NanoCore

Pieter Cullis

Core Co-Leader
University of British Columbia

Christian Kastrup

Core Co-Leader
University of British Columbia

Karen Chan

NanoCore Operational Lead
University of British Columbia

PharmaCore

Marcel Bally

Core Co-Leader
University of British Columbia

Shyh-Dar (Star) Li

Core Co-Leader
University of British Columbia

Nancy Dos Santos

Core Operational Lead
BC Cancer Agency

NMIN

NHN Executive Committee (2023-24)

The Executive Committee of NMIN’s Highly Qualified Personnel (HQP) Network (NHN) is comprised of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs, activities and other opportunities. The mandate of the NHN Executive Committee is to enhance research and professional networking opportunities for NMIN research trainees and new professionals

Jennyfer Zapata-Farfan

PRESIDENT
Polytechnique Montréal

Michael Valic

VICE-PRESIDENT
University of Toronto

Noorjahan Aibani

Events Director
Precision NanoSystems Inc.

Alexander Baker

Member-at-large
University of Toronto

Amélie Baron

Regional Director – Quebec/Atlantic
Polytechnique Montréal

Ariadne Tuckmantel Bido

Member-at-large
University of British Columbia

Talita de Francesco Calheiros

Member-at-large
University of Victoria

Norman Chow

Communications Director
BC Cancer

Tavonga Mandava

Regional Director – West-Central
University of Saskatchewan

Liza Silverman

Regional Director – Pacific
University of Victoria

Nashmia Zia

Regional Director – Ontario
University of Toronto

NMIN

administration

Administrative Centre Team

The Administrative Centre team consists of the Executive Director, the Executive Assistant, the Finance Manager, the Research and Partnerships Manager, the HQP & Events Coordinator, and the Digital Initiatives Consultant. This team supports and facilitates the work of the network’s Governance, Management and Program teams, and is responsible for the network’s day-to-day operations.

Diana Royce

Executive Director

dianaroyce@nanomedicines.ca


Diana Royce

Executive Director

dianaroyce@nanomedicines.ca


Marshall Beck

Digital Initiatives / Communications Manager

email

Rasika Kulkarni

Manager, Research Administration

email

Divya Rao

Manager, HQP Programs & Network Events

email

Diana Royce

Executive Director

dianaroyce@nanomedicines.ca

Maria Barros

Executive Assistant

mariabarros@nanomedicines.ca

Marshall Beck

Digital Initiatives Consultant

mbeck@nanomedicines.ca

Leah Graystone

HQP & Events Coordinator

leahgraystone@nanomedicines.ca

Andrew Kim

Accountant

andrewkim@nanomedicines.ca

Daniel Rogers

Manager, Research & Partnerships

danrogers@nanomedicines.ca

NMIN

CONTACT

NMIN

2350 Health Sciences Mall, Room 5451

University of British Columbia

Vancouver, BC V6T 1Z3

Canada

info@nanomedicines.ca